Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet

v2.4.0.6
Balance Sheet (USD $)
Mar. 31, 2013
Dec. 31, 2012
Current Assets:    
Cash and cash equivalents $ 12,069,028 $ 13,486,543
Marketable securities (note 3) 100,000 100,000
Prepaid expenses and other current assets (note 4) 183,320 188,808
Total Current Assets 12,352,348 13,775,351
Restricted Cash Equivalents (note 16) 957,180 1,091,801
Equipment, Net (note 6) 43,449 52,156
Total Assets 13,352,977 14,919,308
Current Liabilities:    
Accounts payable and accrued expenses (note 7) 976,166 851,837
Deferred Research and Development Arrangement (note 8) 1,472,629 1,626,000
Other Liabilities (note 9) 55,184 65,417
Warrant Liabilities (note 13) 2,473,163 2,842,065
Total Liabilities 4,977,142 5,385,319
Commitments and Contingencies (note 16)      
Stockholders' Equity (note 11):    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding 0 0
Common stock, par value $0.0001, 500,000,000 authorized shares, 119,443,194 issued and 119,428,989 oustanding 11,944 11,944
Additional paid-in capital 73,233,689 72,861,738
Accumulated deficit during the development stage (64,841,388) (63,311,283)
Treasury stock, 14,205 shares, at cost (28,410) (28,410)
Total Stockholders' Equity 8,375,835 9,533,989
Total Liabilities and Stockholders' Equity $ 13,352,977 $ 14,919,308